Heterogeneity in Drug Utilization in Three European Countries: A Study of Dopamine Agonists

Aug-10

AUTHORS : Gianluca Trifirò, Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 1, Consolare Valeria Street, 98125, Messina, Italy AND Department of Medical Informatics, Erasmus Medical Centre, Rotterdam, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands – Email: trifirog@unime.it – Profile: https://www.unime.it/it/persona/gianluca-trifir%C3%B2

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 19(S1):278-279

DOI : 10.1002/pds.2019

Heterogeneity in Drug Utilization in Three European Countries: A Study of Dopamine Agonists

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study